Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma
Clinical and Translational Medicine · 2024-06 · 14 (6)
DOI: 10.1002/ctm2.1727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 28.05.2024. Verfasst von Shuai Yang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology & Oncology, Jiangbei Campus, The First Affiliated Hospital of Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major International (Regional) Joint Research Program of the National Natural Science Foundation of China, Funding for National Clinical Key Specialty (Oncology), Funding for Chongqing Young Expert Studio, and Funding for Chongqing Young and Middle-Aged Medical Excellence Team.
Abstract (Originalsprache)
Background
The liver is anatomically divided into eight segments based on the distribution of Glisson's triad. However, the molecular mechanisms underlying each segment and its association with hepatocellular carcinoma (HCC) heterogeneity are not well understood. In this study, our objective is to conduct a comprehensive multiomics profiling of the segmentation atlas in order to investigate potential subtypes and therapeutic approaches for HCC.
Methods
A high throughput liquid chromatography‐tandem mass spectrometer strategy was employed to comprehensively analyse proteome, lipidome and metabolome data, with a focus on segment‐resolved multiomics profiling. To classify HCC subtypes, the obtained data with normal reference profiling were integrated. Additionally, potential therapeutic targets for HCC were identified using immunohistochemistry assays. The effectiveness of these targets were further validated through patient‐derived organoid (PDO) assays.
Results
A multiomics profiling of 8536 high‐confidence proteins, 1029 polar metabolites and 3381 nonredundant lipids was performed to analyse the segmentation atlas of HCC. The analysis of the data revealed that in normal adjacent tissues, the left lobe was primarily involved in energy metabolism, while the right lobe was associated with small molecule metabolism. Based on the normal reference atlas, HCC patients with segment‐resolved classification were divided into three subtypes. The C1 subtype showed enrichment in ribosome biogenesis, the C2 subtype exhibited an intermediate phenotype, while the C3 subtype was closely associated with neutrophil degranulation. Furthermore, using the PDO assay, exportin 1 (XPO1) and 5‐lipoxygenase (ALOX5) were identified as potential targets for the C1 and C3 subtypes, respectively.
Conclusion
Our extensive analysis of the segmentation atlas in multiomics profiling defines molecular subtypes of HCC and uncovers potential therapeutic strategies that have the potential to enhance the prognosis of HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology & Oncology, Jiangbei Campus, The First Affiliated Hospital of Army Medical University, Chongqing, China.
- Department of Hepatobiliary Surgery, Xinqiao Hospital, Army Medical University, Chongqing, China.
- State Key Laboratory of Genetic Engineering, Institutes of Biomedical Sciences, Human Phenome Institute, School of Life Sciences, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China.
- Department of Gastroenterology, Xinqiao Hospital, Army Medical University, Chongqing, China.
- Department of Radiology, Xinqiao Hospital, Army Medical University, Chongqing, China.
ORCID-Profile: Lu Zheng, Chen Ding, Yongsheng Li
Förderung
- Major International (Regional) Joint Research Program of the National Natural Science Foundation of China
- Funding for National Clinical Key Specialty (Oncology)
- Funding for Chongqing Young Expert Studio, and Funding for Chongqing Young and Middle-Aged Medical Excellence Team
Zitieren
APA
Yang, S., Zheng, L., Li, L., Zhang, J., Wang, J., Zhao, H., Chen, Y., Liu, X., Gan, H., Chen, J., Yan, M., He, C., Li, K., Ding, C., & Li, Y. (2024). Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma. Clinical and Translational Medicine, 14(6). https://doi.org/10.1002/ctm2.1727
Vancouver
Yang S, Zheng L, Li L, Zhang J, Wang J, Zhao H, et al. Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma. Clinical and Translational Medicine. 2024;14(6). doi:10.1002/ctm2.1727
BibTeX
@article{Yang2024,
author = {Yang, Shuai and Zheng, Lu and Li, Lingling and Zhang, Jiangang and Wang, Jingchun and Zhao, Huakan and Chen, Yu and Liu, Xudong and Gan, Hui and Chen, Junying and Yan, Mei and He, Chuanyin and Li, Kai and Ding, Chen and Li, Yongsheng},
title = {Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma},
journal = {Clinical and Translational Medicine},
year = {2024},
volume = {14},
number = {6},
doi = {10.1002/ctm2.1727}
}
EUVIMED